Progenics Pharmaceuticals Reviews

Rating Trends
Recommend to a friend
Approve of CEO
Progenics Pharmaceuticals CEO, General Counsel, Secretary, and Director Mark R. Baker
Mark R. Baker
2 Ratings
  • Progenics Server Administrator

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Former Contractor - Server Administrator in Tarrytown, NY
    Former Contractor - Server Administrator in Tarrytown, NY
    Neutral Outlook
    No opinion of CEO

    I worked at Progenics Pharmaceuticals as a contractor (More than a year)


    Excellent Staff/Peers, GREAT Manager of IT Mathew Storms, GREAT Supervisor but gone now John Miele. Well run lean company, above average benefits, treat employees extremely well. Very Competitive wages too.


    Because they are a Pharmaceutical Company, their livelihood depends on inventing/developing new products. If their Scientists don't come up with a "Wonder Drug" every 4-5 years, stability is an issue from a employment perspective. TOO MUCH documentation to the point of overkill (and I was in the Military 10 Years, so that's saying something). There is duplication and excessive bureaucracy which eventually HAS to effect their bottom line, which if effectively minimized/managed, could save the company enough $$$ to keep more employees on.

Progenics Pharmaceuticals Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Declined Offer
    Positive Experience
    Average Interview


    I applied through an employee referral. The process took 1 day. I interviewed at Progenics Pharmaceuticals in January 2009.


    last about 2 hours. went through resume with each interviewer and they asked a few technical questions based on your resume. one of the interviewer arrived late. just chat with the hiring manager while waiting.

Progenics Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Tarrytown, NY
Size 50 to 149 Employees
Founded 1986
Type Company - Public (PGNX)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

Progenics Pharmaceuticals is taking a proactive approach to fighting serious diseases. The company develops biotech drugs with oncology and virology applications, as well as therapeutics used in clinical care settings. Progenics' commercial product Relistor, which blocks the side effects of opioids without lessening their pain-killing power, is approved as an injectable treatment for opioid-induced constipation (OIC) in terminally ill patients. The drug was developed in collaboration with Wyeth Pharmaceuticals (now part of Pfizer). Also in the firm's pipeline are ... More

Work at Progenics Pharmaceuticals? Share Your Experiences

Progenics Pharmaceuticals

Click to Rate